This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct;13(5):377-8.

doi: 10.1007/s11926-011-0195-5.

Inhibition of spleen tyrosine kinase for rheumatoid arthritis

Aarat M Patel¹, Daniel Lupash, Douglas Chew, Marc C Levesque, Larry W Moreland

Affiliations

PMID: 21748415
DOI: 10.1007/s11926-011-0195-5

Comment

Inhibition of spleen tyrosine kinase for rheumatoid arthritis

Aarat M Patel et al. Curr Rheumatol Rep. 2011 Oct.

. 2011 Oct;13(5):377-8.

doi: 10.1007/s11926-011-0195-5.

Authors

Aarat M Patel¹, Daniel Lupash, Douglas Chew, Marc C Levesque, Larry W Moreland

Affiliation

¹ Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

PMID: 21748415
DOI: 10.1007/s11926-011-0195-5

No abstract available

PubMed Disclaimer

Comment on

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.
Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB, Magilavy DB. Weinblatt ME, et al. N Engl J Med. 2010 Sep 30;363(14):1303-12. doi: 10.1056/NEJMoa1000500. Epub 2010 Sep 22. N Engl J Med. 2010. PMID: 20879879 Clinical Trial.

References

1. Arthritis Rheum. 2008 Nov;58(11):3309-18 - PubMed
1. Arthritis Rheum. 2011 Feb;63(2):337-45 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer